Could I Have SAD?
Take the quiz.
Could I Have OCD?
Take the quiz.
Healthcare
Professionals
Get important information
and facts about LUVOX CR.
Privacy Policy
Jazz Pharmaceuticals, Inc., is committed to providing its users with an Internet experience that respects and protects their personal privacy choices and concerns. We have created this privacy statement in order to demonstrate our firm commitment to privacy. The following discloses our information gathering and dissemination practices for this Web site. This site contains links to other sites. Jazz Pharmaceuticals, Inc., is not responsible for the privacy practices or the content of such Web sites.
Your Privacy Rights
Jazz Pharmaceuticals, Inc., is committed to keeping your information private and confidential. Please be assured that Jazz Pharmaceuticals, Inc., does not sell or release any personal information of Web site visitors to any third party.
Traffic Data Collected
When you use our site, we collect anonymous information. Anonymous information is information about how you use our site (such as places visited and searches performed). Anonymous information also includes the domain names and/or IP addresses of browsers that visit our site, time of day the site was visited, and other non-personally identifiable information. Anonymous information is information that is not tied to any individual, but helps to characterize users to improve our services.
Personal Information Collected
Our site uses an order form for customers to request information, products, and services. We collect a visitor's contact information (such as an e-mail address, phone numbers, names, mailing address, etc.). This information is only used to fulfill order requests.
The visitor's contact information is also used to get in touch with the visitor when necessary. For example, we might have a question about the processing of an order. If a user so requests, we may use the contact information to send the user additional information.
The personally identifiable information we collect is not used for any purposes other than order fulfillment and dissemination of information. It is not disclosed to anyone other than Jazz Pharmaceuticals, Inc., and its partners, contractors and agents, unless we must do so to comply with a court order or other legal process, or we must do so to protect our rights or property.
Please note that Jazz Pharmaceuticals, Inc., will not intentionally share the contents of any email or form submitted through this site with any third party, except as stated above. However, due to the nature of electronic communications, we cannot and do not provide assurances that the contents will not become known or accessible to third parties.
Appropriate Users
This site is intended for the exclusive use of registered users who are residents of the United States of America. It is not our intent to gather personally identifying information from individuals residing outside of the United States. The type of personally identifying information, the manner in which it is collected and the specified uses of the collected information may not be legal in certain countries outside of the United States. Because of these various laws, regulations, and medical practices, information designated to be used in one country may not be approved for use outside of that county. Therefore, collection of personally identifying information on the site may not be appropriate for residents of other countries. THE SITE IS DESIGNED TO COMPLY WITH THE LAWS AND REGULATIONS OF THE UNITED STATES ONLY. Nothing on the site should be considered a solicitation or promotion of any product or an indication for any product that is not permitted by the laws or regulations of the country where the user of the product resides.
Site content and services are intended for users who are at least 18 years of age or older. The site is not intended to attract children under the age of 13 or adolescents under the age of 18. We do not knowingly collect information from any person we actually know is under the age of 18.
Contacting the Web Site
If you have any questions about this privacy statement, the practices of this site, or your dealings with this Web site, you may contact:
Jazz Pharmaceuticals
3180 Porter Drive
Palo Alto, CA 94304
Updates and Changes to Privacy Policy
We reserve the right, at any time to add to, change, update or modify this privacy policy, simply by posting such change, update or modification on the site. Any such change, update or modification will be effective immediately upon posting.
Once-A-Day LUVOX® CR (fluvoxamine maleate) Extended-Release Capsules are indicated for the treatment of social anxiety disorder (SAD) and obsessive compulsive disorder (OCD).
Important Safety Information
CONTRAINDICATIONS
The use of alosetron, tizanidine, thioridazine, or pimozide with LUVOX CR Capsules is contraindicated. The use of MAO inhibitors in combination with LUVOX CR Capsules, or within 14 days of discontinuing treatment with LUVOX CR Capsules, is contraindicated (see WARNINGS and PRECAUTIONS). LUVOX CR Capsules are also contraindicated in patients with a history of hypersensitivity to fluvoxamine maleate or any of its excipients.
ADVERSE EVENTS
In clinical trials, the most commonly observed adverse events with an incidence of ≥5% and at least twice that of placebo were nausea, somnolence, asthenia, diarrhea, anorexia, tremor, and sweating. Overall, these side effects were mild to moderate in severity and transient in nature. Other common adverse events (≥5% and at least twice that of placebo) included abnormal ejaculation and anorgasmia.
Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of LUVOX® CR (fluvoxamine maleate) Extended-Release Capsules or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. LUVOX CR Capsules are not approved for use in pediatric patients. (See WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use.)
Please see full prescribing information, including boxed warning, for LUVOX CR.
LUVOX is a registered trademark of Solvay Pharmaceuticals, Inc.
© 2008 Jazz Pharmaceuticals, Inc.
